Method and compositions for treating viral infection
AssigneePhoenix Biotechnology, Inc.
InventorsRobert A. Newman, Otis C. Addington
Life of this patent
Estimating the term…
Abstract
A method of treating viral infection, such as viral infection caused by a virus of the Filoviridae family, Flaviviridae family (Flavivirus genus), Deltaretrovirus genus, or Togaviriade family is provided. A composition having at least one cardiac glycoside is used to treat viral infection. The composition can further include at least one triterpene. Alternatively, the composition comprises at least one, at least two, or at least three triterpenes.
Claims20
A method of treating HTLV-1 virus infection, in a subject in need thereof, the method comprising administering to the subject one or more doses of an antiviral composition comprising a) oleandrin;
- or b) a combination of oleandrin and at least two triterpenes selected from the group consisting of a) oleanolic acid, a salt, or prodrug thereof, b) ursolic acid, a salt, or prodrug thereof, and e) betulinic acid, a salt, or prodrug thereof.
A prophylactic method of treating a subject at risk of contracting a HTLV-1 virus infection, the method comprising chronically administering to the subject one or more doses of an antiviral composition on a recurring basis over an extended treatment period prior to the subject contracting the viral infection, thereby preventing the subject from contracting the viral infection;
- wherein the antiviral composition comprises a) oleandrin;
- or b) a combination of oleandrin and at least two triterpenes selected from the group consisting of a) oleanolic acid, a salt, or prodrug thereof, b) ursolic acid, a salt, or prodrug thereof, and e) betulinic acid, a salt, or prodrug thereof.
A method of treating HTLV-1 virus infection, the method comprising chronically administering to a subject in need thereof one or more doses of antiviral composition comprising oleandrin.
Dependencies are inferred from the claim text.